메뉴 건너뛰기




Volumn 284, Issue 10, 2000, Pages 1280-1283

Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

EID: 0034644401     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.10.1280     Document Type: Article
Times cited : (154)

References (12)
  • 1
    • 0007916399 scopus 로고    scopus 로고
    • Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation before and during radiotherapy in locally advanced carcinoma of the prostate. From: 42nd Annual Meeting of the American Society of Therapeutic Radiology and Oncology; October 22, 2000; Boston, Mass
    • (2000)
    • Pilepich, M.V.1    Winter, K.2    Roach, M.3
  • 3
    • 0032538069 scopus 로고    scopus 로고
    • Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    • (1998) JAMA , vol.280 , pp. 969-974
    • D'Amico, A.V.1    Whittington, R.2    Malkowicz, S.B.3
  • 8
    • 0029059020 scopus 로고
    • Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxMO) prostate cancer
    • (1995) J Urol , vol.154 , pp. 424-428
    • Soloway, M.S.1    Sharifi, R.2    Wajsman, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.